Search
Search Results
##search.searchResults.foundPlural##
-
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2105PDF: 1306HTML: 3491 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3274PDF: 1219HTML: 2184 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3811Suppl. Files: 1075PDF: 1039Html: 157 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1257PDF: 993HTML: 111 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3245PDF: 1927HTML: 7461 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2180PDF: 925HTML: 6771Figure 1: 161 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3195PDF: 1692HTML: 1075 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3330PDF: 1256HTML: 2202Fi.1 Gritti.Rambaldi: 192 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2122PDF: 1554HTML: 251 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4007PDF: 1124HTML: 1923Fig.1: 209Fig. 2: 104Table 1: 192Table2: 206Table 3: 186 -
PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries
1216PDF: 832HTML: 268 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1002PDF: 904Suppl. Files: 582HTML: 76 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2850PDF: 1334HTML: 3556Untitled: 181Untitled: 190Untitled: 167 -
-
SOLITARY PLASMACYTOMA
3792PDF: 2151HTML: 1206fIGURES 1,2: 197 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
1987PDF: 781HTML: 1030 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3666PDF: 1063HTML: 2270Figure 1: 201 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1201PDF: 579HTML: 217 -
Anemia in the elderly: not always what it seems.
3270PDF: 1000HTML: 1759Figure 1: 164Figure 1 revised: 167 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2491PDF: 849HTML: 2111 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3628PDF: 1407HTML: 172 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1469PDF: 525HTML: 689 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1478PDF: 368HTML: 196 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
1988PDF: 802HTML: 203 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1470PDF: 912HTML: 214 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
1736PDF: 674HTML: 2396Untitled: 138Figure 1 a: 144Figure 1 b: 157Fig 1 c: 135Figure 1 d: 181 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2549PDF: 1584HTML: 2344Table1: 181 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1347PDF: 867HTML: 1778 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3483PDF: 2372HTML: 1433







